Benefits of a dedicated cystic fibrosis pharmacist.
作者信息
Redfern J, Webb A K
机构信息
Manchester Adult Cystic Fibrosis Centre, Wythenshawe Hospital, Manchester M23 9LT, UK. Jan.redfern@
出版信息
J R Soc Med. 2004;97 Suppl 44(Suppl 44):2-7.
Abstract
摘要
相似文献
1
Benefits of a dedicated cystic fibrosis pharmacist.
J R Soc Med. 2004;97 Suppl 44(Suppl 44):2-7.
2
Community pharmacist-led clinical services: physician's understanding, perceptions and readiness to collaborate in a Midwestern state in the United States.
Int J Pharm Pract. 2018 Oct;26(5):407-413. doi: 10.1111/ijpp.12421. Epub 2017 Dec 7.
3
Effectiveness and cost effectiveness of pharmacist input at the ward level: a systematic review and meta-analysis.
Res Social Adm Pharm. 2019 Oct;15(10):1212-1222. doi: 10.1016/j.sapharm.2018.10.006. Epub 2018 Oct 19.
4
Benefit of Incorporating Clinical Pharmacists in an Adult Intensive Care Unit: A Cost-saving Study.
J Clin Pharm Ther. 2020 Oct;45(5):1127-1133. doi: 10.1111/jcpt.13195. Epub 2020 Jun 4.
5
Restructuring supervision and reconfiguration of skill mix in community pharmacy: Classification of perceived safety and risk.
Res Social Adm Pharm. 2016 Sep-Oct;12(5):733-46. doi: 10.1016/j.sapharm.2015.10.009. Epub 2015 Oct 31.
6
A developmental evaluation of an intraprofessional Pharmacy Communication Partnership (PROMPT) to improve transitions in care from hospital to community: A mixed-methods study.
BMC Health Serv Res. 2020 Feb 10;20(1):99. doi: 10.1186/s12913-020-4909-0.
7
Strategies for community-based medication management services in value-based health plans.
Res Social Adm Pharm. 2017 Jan-Feb;13(1):48-62. doi: 10.1016/j.sapharm.2016.01.005. Epub 2016 Jan 21.
8
Multifaceted Pharmacist-led Interventions in the Hospital Setting: A Systematic Review.
Basic Clin Pharmacol Toxicol. 2018 Oct;123(4):363-379. doi: 10.1111/bcpt.13030. Epub 2018 Jun 13.
9
Opportunities to improve clinical outcomes and challenges to implementing clinical pharmacists into health care teams.
Prim Care. 2012 Dec;39(4):615-26. doi: 10.1016/j.pop.2012.08.005. Epub 2012 Oct 1.
10
Changing status in health care: community and hospital pharmacists' perceptions of pharmacy practice.
Int J Pharm Pract. 2019 Jun;27(3):249-255. doi: 10.1111/ijpp.12505. Epub 2018 Dec 28.
引用本文的文献
1
The role of the clinical pharmacist in the respiratory or sleep multidisciplinary team.
Breathe (Sheff). 2023 Dec;19(4):230123. doi: 10.1183/20734735.0123-2023. Epub 2023 Dec 19.
2
Impact of pharmacy services on time to elexacaftor-tezacaftor-ivacaftor initiation.
J Manag Care Spec Pharm. 2022 Sep;28(9):989-996. doi: 10.18553/jmcp.2022.28.9.989.
3
Using A Work System Framework to Investigate Pharmacists' Roles in Cystic Fibrosis Management.
J Pediatr Pharmacol Ther. 2022;27(3):270-276. doi: 10.5863/1551-6776-27.3.270. Epub 2022 Mar 21.
4
Virtual medication tours with a pharmacist as part of a cystic fibrosis telehealth visit.
J Am Pharm Assoc (2003). 2021 Sep-Oct;61(5):e119-e125. doi: 10.1016/j.japh.2021.04.005. Epub 2021 Apr 20.
5
Real-World Safety of CFTR Modulators in the Treatment of Cystic Fibrosis: A Systematic Review.
J Clin Med. 2020 Dec 23;10(1):23. doi: 10.3390/jcm10010023.
6
Opportunities for Outpatient Pharmacy Services for Patients with Cystic Fibrosis: Perceptions of Healthcare Team Members.
Pharmacy (Basel). 2019 Apr 3;7(2):34. doi: 10.3390/pharmacy7020034.
7
[Not Available].
Can J Hosp Pharm. 2014 May;67(3):230-9.
8
European Cystic Fibrosis Society Standards of Care: Framework for the Cystic Fibrosis Centre.
J Cyst Fibros. 2014 May;13 Suppl 1:S3-22. doi: 10.1016/j.jcf.2014.03.009.
本文引用的文献
1
Annual review hospital visits for patients with cystic fibrosis.
J R Soc Med. 2001;94 Suppl 40(Suppl 40):12-6. doi: 10.1177/014107680109440s05.
Zotero 插件